Publs. oficiales Innate Pharma

Acciones

En tiempo real Euronext Paris Otros sitios de cotización 16:35:57 14/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2,33 ^EUR	+1,30 %		+1,75 %	-11,07 %

15/04	Innate Pharma anuncia que el activador de células NK SAR443579 / IPH6101, desarrollado por Sanofi, avanza a la fase 2 para pacientes con cáncer de sangre	CI
10/04	Innate Pharma S.A. presenta en AACR 2024 la eficacia preclínica de su candidato a fármaco pre-IND IPH45, un novedoso conjugado anticuerpo-fármaco contra la Nectina-4	CI

Minutes of the general assembly	12/05/23	CO
Slide show Q1	10/05/23	CO
1st quarter turnover	10/05/23	CO
1st quarter turnover	10/05/23	CO
Monthly statement on voting rights	09/05/23	CO
Monthly statement on voting rights	09/05/23	CO
Mixed general Shareholders meeting notice	21/04/23	CO
Combined general shareholders meeting	07/04/23	CO
SEC Filing 20 F	05/04/23	CO
Universal registration document	05/04/23	CO
Slide show results	23/03/23	CO
Annual results	23/03/23	CO
Annual results	23/03/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	05/12/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	25/11/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	22/11/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	22/11/22	CO
Slide show Q3	14/11/22	CO
3rd quarter results	14/11/22	CO
3rd quarter results	14/11/22	CO
Threshold crossings	21/10/22	CO
Provisional calendar	20/10/22	CO
Provisional calendar	20/10/22	CO
Slide show half-year results	15/09/22	CO
1st-half-year results	15/09/22	CO